2,451
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

The effectiveness of resveratrol in treatment of PCOS on the basis of experimental model in rats

ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon
Pages 54-57 | Received 03 Sep 2021, Accepted 14 Sep 2021, Published online: 23 Dec 2021

References

  • Neven ACH, Laven J, Teede HJ, et al. A summary on polycystic ovary syndrome: diagnostic criteria, prevalence, clinical manifestations, and management according to the latest international guidelines. Semin Reprod Med. 2018;36(1):5–12.
  • Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–47.
  • Final Report National Institute of Health [Internet]. Evidence-based methodology workshop on polycystic ovary syndrome December 3–5, 2012. Bethesda (MD): NIH; 2012 [cited 2017 Feb 7]. Available from: http://prevention.nih.gov/workshops/2012/pcos/resourc-es.aspx
  • Moran C, Arriaga M, Rodriguez G, et al. Obesity differentially affects phenotypes of polycystic ovary syndrome. Int J Endocrinol. 2012; 2012:317241.
  • Murri M, Luque-ram’ırez M, Insenser MM, et al. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and Meta-analysis. Hum Reprod Update. 2013;19(3):268–288.
  • Zhang J, Fan P, Liu H, et al. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS. Hum Reprod. 2012;27(8):2484–2493.
  • Diamanti-Kandarakis E, Chatzigeorgiou A, Papageorgiou E, et al. Advanced glycation end-products and insulin signaling in granulosa cells. Exp Biol Med. 2016;241(13):1438–1445.
  • Qi B, Shi C, Meng J, et al. Resveratrol alleviates ethanol-induced neuroinflammation in vivo and in vitro: involvement of TLR2-MyD88-NF-κB pathway. Int J Biochem Cell Biol. 2018;103:56–64.
  • Gao Y, Kang L, Li C, et al. Resveratrol ameliorates diabetes-induced cardiac dysfunction through AT1R-ERK/p38 MAPK signaling pathway. Cardiovasc Toxicol. 2016;16(2):130–137.
  • Guo S, Yao Q, Ke Z, et al. Resveratrol attenuates high glucose-induced oxidative stress and cardiomyocyte apoptosis through AMPK. Mol Cell Endocrinol. 2015;412:85–94.
  • Harati K, Slodnik P, Chromik AM, et al. Resveratrol induces apoptosis and alters gene expression in human fibrosarcoma cells. Anticancer Res. 2015;35(2):767–774.
  • Wu XP, Xiong M, Xu CS, et al. Resveratrol induces apoptosis of human chronic myelogenous leukemia cells in vitro through p38 and JNK-regulated H2AX phosphorylation. Acta Pharmacol Sin. 2015;36(3):353–361.
  • Singh CK, Kumar A, Hitchcock DB, et al. Resveratrol prevents embryonic oxidative stress and apoptosis associated with diabetic embryopathy and improves glucose and lipid profile of diabetic dam. Mol Nutr Food Res. 2011;55(8):1186–1196.
  • MacCarrone M, Lorenzon T, Guerrieri P, et al. Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity. Eur J Biochem. 1999;265(1):27–34.
  • Kong XX, Fu YC, Xu JJ, et al. Resveratrol, an effective regulator of ovarian development and oocyte apoptosis. J Endocrinol Invest. 2011;34(11):e374–e381.
  • WMA DECLARATION OF HELSINKI – ETHICAL PRINCIPLES FOR MEDICAL RESEARCH INVOLVING HUMAN SUBJECTS, 64th WMA General Assembly, Fortaleza, Brazil, October 2013.
  • Rencber SF, Ozbek KS, Eraldemır C, et al. Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study. J Ovarian Res. 2018;11(1):55.
  • Zhang N, Zhuang L, Gai S, et al. Beneficial phytoestrogenic effects of resveratrol on polycystic ovary syndromein rat model. Gynecol Endocrinol. 2021;37(4):337–335.
  • Ghowsi M, Khazali H, Sisakhtnezhad S. The effect of resveratrol on oxidative stress in the liver and serum of a rat model of polycystic ovary syndrome: an experimental study. Int J Reprod Biomed. 2018;16(3):149–158.
  • Merhi Z. Advanced glycation end products and their relevance in female reproduction. Hum Reprod. 2014;29(1):135–145.
  • Fujii EY, Nakayama M. The measurements of RAGE, VEGF, and AGEs in the plasma and follicular fluid of reproductive women: the influence of aging. Fertil Steril. 2010;94(2):694–700.